Literature DB >> 9038312

Purification and in vitro activities of rabbit platelet microbicidal proteins.

M R Yeaman1, Y Q Tang, A J Shen, A S Bayer, M E Selsted.   

Abstract

Recent in vitro studies have demonstrated that rabbit platelets release a small, cationic antimicrobial protein in response to thrombin stimulation under physiological conditions (M. R. Yeaman, S. M. Puentes, D. C. Norman, and A. S. Bayer, Infect. Immun. 60:1202-1209, 1992). This observation prompted our present investigation, focused on determining the array of antimicrobial proteins contained within rabbit platelets and their in vitro activity against common bloodstream pathogens. A group of small (6.0- to 9.0-kDa), cationic proteins with in vitro antimicrobial activity was purified from whole and thrombin-stimulated rabbit platelets by gel filtration and reversed-phase high-performance liquid chromatography. Purified proteins in micromolar concentrations (10 to 40 microg/ml) exerted in vitro microbiostatic and/or microbicidal activities against Staphylococcus aureus, Escherichia coli, and Candida albicans in a dose-dependent manner. The antimicrobial activities of proteins purified from rabbit platelet acid extracts were generally inversely related to pH, with maximal activity observed at pH 5.5. In contrast, the predominant protein isolated from thrombin-stimulated rabbit platelets, though biochemically and microbiologically similar to proteins extracted by acid, exhibited antimicrobial activities which were modestly enhanced at pH 7.2 compared with pH 5.5. Amino acid compositional analyses in combination with molecular mass determinations suggest that the majority of these proteins are distinct molecules not derived from a single common precursor. Collectively, these data indicate that rabbit platelets contain proteins which exert potent in vitro antimicrobial activity against bacterial and fungal pathogens which commonly invade the bloodstream. Moreover, several of these proteins were released from platelets stimulated with thrombin under physiological conditions and exerted potent antimicrobial activities in physiological pH ranges. These observations support the hypothesis that platelets serve an important role in host defense against infection, via localized release of antimicrobial proteins in response to stimuli associated with tissue injury or microbial colonization.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9038312      PMCID: PMC175084     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  49 in total

1.  Neutrophil defensins: purification, characterization, and antimicrobial testing.

Authors:  S S Harwig; T Ganz; R I Lehrer
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

2.  Activation of monocytes and platelets by monoclonal antibodies or malaria-infected erythrocytes binding to the CD36 surface receptor in vitro.

Authors:  C F Ockenhouse; C Magowan; J D Chulay
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

3.  In vitro resistance to platelet microbicidal protein correlates with endocarditis source among bacteremic staphylococcal and streptococcal isolates.

Authors:  T Wu; M R Yeaman; A S Bayer
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

4.  Thrombin-induced rabbit platelet microbicidal protein is fungicidal in vitro.

Authors:  M R Yeaman; A S Ibrahim; J E Edwards; A S Bayer; M A Ghannoum
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

5.  Involvement of bactericidal factors from thrombin-stimulated platelets in clearance of adherent viridans streptococci in experimental infective endocarditis.

Authors:  J Dankert; J van der Werff; S A Zaat; W Joldersma; D Klein; J Hess
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

6.  Factors associated with bacteraemia in febrile, granulocytopenic cancer patients. The International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC).

Authors:  C Viscoli; P Bruzzi; E Castagnola; L Boni; T Calandra; H Gaya; F Meunier; R Feld; S Zinner; J Klastersky
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

7.  Effect of thrombocytopenia on the early course of streptococcal endocarditis.

Authors:  P M Sullam; U Frank; M R Yeaman; M G Täuber; A S Bayer; H F Chambers
Journal:  J Infect Dis       Date:  1993-10       Impact factor: 5.226

8.  Resistance to platelet microbicidal protein results in increased severity of experimental Candida albicans endocarditis.

Authors:  M R Yeaman; S S Soldan; M A Ghannoum; J E Edwards; S G Filler; A S Bayer
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

9.  Purification of staphylocidal beta-lysin from rabbit serum.

Authors:  F B Johnson; D M Donaldson
Journal:  J Bacteriol       Date:  1968-09       Impact factor: 3.490

10.  Cellular source and charcter of a heatstable bactericidal property associated with rabbit and rat platelets.

Authors:  R JAGO; R F JACOX
Journal:  J Exp Med       Date:  1961-04-01       Impact factor: 14.307

View more
  66 in total

1.  Thrombin-induced platelet microbicidal protein susceptibility phenotype influences the outcome of oxacillin prophylaxis and therapy of experimental Staphylococcus aureus endocarditis.

Authors:  V K Dhawan; A S Bayer; M R Yeaman
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

2.  In vitro antibacterial activities of platelet microbicidal protein and neutrophil defensin against Staphylococcus aureus are influenced by antibiotics differing in mechanism of action.

Authors:  Y Q Xiong; M R Yeaman; A S Bayer
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

3.  Membrane permeabilization by thrombin-induced platelet microbicidal protein 1 is modulated by transmembrane voltage polarity and magnitude.

Authors:  S P Koo; A S Bayer; B L Kagan; M R Yeaman
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

4.  Staphylococcus aureus, Platelets, and the Heart.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-08       Impact factor: 3.725

5.  Diversity in antistaphylococcal mechanisms among membrane-targeting antimicrobial peptides.

Authors:  S P Koo; A S Bayer; M R Yeaman
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

6.  Adherence of platelets to Candida species in vivo.

Authors:  R Robert; S Nail; A Marot-Leblond; J Cottin; M Miegeville; S Quenouillere; C Mahaza; J M Senet
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

7.  DltABCD- and MprF-mediated cell envelope modifications of Staphylococcus aureus confer resistance to platelet microbicidal proteins and contribute to virulence in a rabbit endocarditis model.

Authors:  Christopher Weidenmaier; Andreas Peschel; Volkhard A J Kempf; Natalie Lucindo; Michael R Yeaman; Arnold S Bayer
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

8.  Factors influencing time to vancomycin-induced clearance of nonendocarditis methicillin-resistant Staphylococcus aureus bacteremia: role of platelet microbicidal protein killing and agr genotypes.

Authors:  Pamela A Moise; Alan Forrest; Arnold S Bayer; Yan Q Xiong; Michael R Yeaman; George Sakoulas
Journal:  J Infect Dis       Date:  2010-01-15       Impact factor: 5.226

9.  Platelet antistaphylococcal responses occur through P2X1 and P2Y12 receptor-induced activation and kinocidin release.

Authors:  Darin A Trier; Kimberly D Gank; Deborah Kupferwasser; Nannette Y Yount; William J French; Alan D Michelson; Leon I Kupferwasser; Yan Q Xiong; Arnold S Bayer; Michael R Yeaman
Journal:  Infect Immun       Date:  2008-09-29       Impact factor: 3.441

10.  Failures in clinical treatment of Staphylococcus aureus Infection with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry, and drug binding.

Authors:  Tiffanny Jones; Michael R Yeaman; George Sakoulas; Soo-Jin Yang; Richard A Proctor; Hans-Georg Sahl; Jacques Schrenzel; Yan Q Xiong; Arnold S Bayer
Journal:  Antimicrob Agents Chemother       Date:  2007-10-22       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.